Novartis AG
NVS · NYSE
9/29/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $3,930 | $4,024 | $3,606 | $2,818 |
| Dep. & Amort. | $1,364 | $1,256 | $1,150 | $1,628 |
| Deferred Tax | $266 | $507 | $798 | $465 |
| Stock-Based Comp. | $268 | $267 | $262 | $272 |
| Change in WC | $1,336 | $442 | -$1,768 | $5 |
| Other Non-Cash | -$593 | $168 | -$403 | -$995 |
| Operating Cash Flow | $6,571 | $6,664 | $3,645 | $4,193 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$354 | -$331 | -$254 | -$558 |
| Net Acquisitions | -$160 | -$1,678 | $6 | -$264 |
| Inv. Purchases | -$100 | -$58 | -$55 | -$2,305 |
| Inv. Sales/Matur. | $179 | $50 | $1,876 | $581 |
| Other Inv. Act. | -$425 | -$226 | -$1,243 | -$487 |
| Investing Cash Flow | -$860 | -$2,243 | $330 | -$3,033 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$511 | $181 | -$523 | -$106 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$2,302 | -$2,714 | -$2,716 | -$2,762 |
| Dividends Paid | $0 | -$2,485 | -$5,333 | $0 |
| Other Fin. Act. | $24 | -$195 | $24 | -$128 |
| Financing Cash Flow | -$2,789 | -$5,213 | -$8,548 | -$2,996 |
| Forex Effect | -$22 | $382 | $180 | -$314 |
| Net Chg. in Cash | $2,900 | -$410 | -$4,393 | -$2,150 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,656 | $7,066 | $11,459 | $13,609 |
| End Cash | $9,556 | $6,656 | $7,066 | $11,459 |
| Free Cash Flow | $5,740 | $6,106 | $2,151 | $3,062 |